UCSD - Altman Clinical and Translational Research Institute (ACTRI)

Public research footprint of UCSD - Altman Clinical and Translational Research Institute (ACTRI), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Myotonic Dystrophy Type 1 (DM1) · Sjögren's Syndrome (SS) · Non-small Cell Lung Carcinoma · Type 2 Diabetes Mellitus

Recently updated registry entries

NCT07486934 — Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants… (Recruiting)
NCT07613294 — A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… (Recruiting)
NCT05968430 — Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of… (Active Not Recruiting)

Work at UCSD - Altman Clinical and Translational Research Institute (ACTRI)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.